VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 392.95 EUR 1.37% Market Closed

Market Cap: €40.8B

V	Vertex Pharmaceuticals Inc XHAM:VX1	US
	Industria de Diseno Textil SA F:IXD1	ES
C	Corning Inc BMV:GLW	US
L	Las Vegas Sands Corp XMUN:LCR	US
P	PayPal Holdings Inc SWB:2PP	US
	Deutsche Wohnen SE F:DWNI	DE

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

49% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

42% > 26%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

50% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.